Skip to main content

HR+/HER2- Metastatic Breast Cancer: Common Presenting Symptoms

Breast Cancer, Video
Videos
Hope Rugo, MD, discusses common presenting symptoms of HR+/HER2- metastatic breast cancer, citing bone metastasis as the most prevalent.

Get TOP in Your Inbox

Stay up to date with the latest oncology pharmacy news and insights by subscribing to our e-newsletter!

SUBSCRIBE

Related Items

Adding Ribociclib to Endocrine Therapy May Reduce Risk for Recurrence in HR-Positive, HER2-Negative, Early Breast Cancer
By Patricia Stewart
July 2023 Vol 16, No 4 – Online Only
ASCO 2023 Highlights, Breast Cancer
FDA Updates Mammography Regulations in MQSA Final Rule
May 2023 Vol 16, No 3
Breast Cancer, Healthcare Policy
Pausing Endocrine Therapy to Become Pregnant Appears Safe for Women with Breast Cancer
By Patricia Stewart
March 2023 Vol 16, No 2
Breast Cancer, SABCS Highlights
Factors Associated with Greater Risk for Abemaciclib Discontinuation in Patients with Early-Stage Breast Cancer
By William King
TOP - November 2022 Vol 15, No 6
Breast Cancer